Ricardo Zwirtes, MD

Infectious disease physician, by training, with over a decade of experience in late-stage drug development across several therapeutic areas. Prior, at Bristol Myers Squibb, led checkpoint inhibitor studies harnessing the immune system to fight against multiple cancers and also therapies for chronic viral infections.